| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | Mazar Andrew Paul | Chief Scientific Officer | Mar 31, 2022 | Option Exercise | $2.55 | 471 | 1,201 | 22,125 | Apr 01, 2022, 05:28 PM | |
| MNPR | Monopar Therapeutics | Mazar Andrew Paul | Chief Scientific Officer | Jan 01, 2022 | Option Exercise | $3.21 | 671 | 2,154 | 20,990 | Jan 04, 2022, 02:49 PM | |
| MNPR | Monopar Therapeutics | Mazar Andrew Paul | Chief Scientific Officer | Dec 31, 2021 | Option Exercise | $3.21 | 556 | 1,785 | 19,724 | Jan 04, 2022, 02:40 PM | |
| MNPR | Monopar Therapeutics | Mazar Andrew Paul | Chief Scientific Officer | Sep 30, 2021 | Option Exercise | $4.87 | 471 | 2,294 | 18,674 | Oct 01, 2021, 07:31 PM | |
| MNPR | Monopar Therapeutics | Mazar Andrew Paul | Chief Scientific Officer | Jun 30, 2021 | Option Exercise | $5.89 | 942 | 5,548 | 17,539 | Jul 02, 2021, 05:11 PM | |
| MNPR | Monopar Therapeutics | Mazar Andrew Paul | Chief Scientific Officer | Feb 11, 2021 | Sale | $14.64 | 125,000 | 1,830,620 | 249,200 | Feb 16, 2021, 07:35 PM | |
| MNPR | Monopar Therapeutics | Mazar Andrew Paul | Chief Scientific Officer | Jan 01, 2021 | Option Exercise | $6.12 | 671 | 4,107 | 15,269 | Jan 05, 2021, 12:00 AM | |
| MNPR | Monopar Therapeutics | Mazar Andrew Paul | Chief Scientific Officer | Dec 18, 2019 | Buy | $8.00 | 125,000 | 1,000,000 | 291,667 | Dec 20, 2019, 06:33 PM |
Menu